An Online Evaluation of Work Chat

December 1, 2025 updated by: Matthew Smith, University of Michigan

An Online Evaluation of Work Chat: A Virtual Workday Among Employed Autistic Adults

This study is aiming to see if it is feasible for the intervention Work Chat to be delivered in a completely online setting to adults with autism spectrum disorder.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Nearly 50,000 youth with autism spectrum disorder (ASD) transition from high school to adult life each year, with only 25% of these transition-age youth with ASD (TAY-ASD) getting jobs within 2 years of graduation. TAY-ASD's ability to sustain employment is even more challenging due in part to their social cognitive deficits (e.g., poorly reading social cues) that disrupt communicating with customers, coworkers, and supervisors. Research shows nearly 90% of job dismissals among TAY-ASD are attributed to poor work-based social functioning (e.g., poorly communicating with upset customers). The subsequent unemployment has damaging effects on their mental, physical, and economic health. A critical gap in federally-mandated services to support youth with ASD as they transition from school-to-adult life is the lack of evidence-based practice to enhance their work-based social functioning. Given that TAY-ASD report computerized training tools are highly acceptable and improve their real-world outcomes, the investigators propose to address this critical barrier to sustained employment by developing and evaluating a novel and scalable computerized training tool to enhance their conversations with customers, coworkers and supervisors at work.

The investigators are aiming to see if it is feasible for Work Chat to be delivered in a completely online setting and not within schools or other sites. The investigators are also evaluating the tool specifically with employed adults who have autism spectrum disorder.

Study Type

Interventional

Enrollment (Actual)

234

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Michigan
      • Ann Arbor, Michigan, United States, 48109
        • University of Michigan

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Autism Spectrum Disorder
  • 18 years or older
  • Has 4th grade or higher reading level
  • Employed or Unemployed and searching for employment within the next 3 months
  • Has access to a computer, laptop, or tablet that has connection to the internet and a camera (not including smartphone)

Exclusion Criteria:

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Work Chat Later
This group will not receive Work Chat during the study, but will receive Work Chat access after data collection is complete.
Experimental: Work Chat Now
Behavioral: Work Chat: An Interactive Virtual Workday Work Chat will be a simulation training using virtual characters to role-play conversations. It will contain conversations with a coworker, a customer, and a supervisor within a workplace setting.
Work Chat will be a simulation training using virtual characters to role-play conversations. It will contain conversations with a coworker, a customer, and a supervisor within a workplace setting.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Emotion Recognition Ability - MiniPONs
Time Frame: Baseline and posttest (approximately 6 weeks after baseline)
Measured by the MiniPONS, which is a short, multichannel version of the established Profile of Nonverbal Sensitivity (PONS) test (Rosenthal et al., 1979). The short multichannel version (64 items) available here correlates very highly with the full version and shows reasonable construct validity through significant correlations with other tests of emotion recognition ability. A total score is calculated at the end, total score can be 0-64, with a higher score being a better outcome.
Baseline and posttest (approximately 6 weeks after baseline)
Change in Theory of Mind - Hinting Task
Time Frame: Baseline and posttest (approximately 6 weeks after baseline)
Measured by the hinting task (Corcoran, Mercer, & Frith, 1995), which comprises 10 short stories describing an interaction between two characters, all of which end with one of the characters making a hint. At the end of each passage, the participant is asked what the hint meant. If they give a correct response (score 2), they move onto the next item. If they fail, they are provided with extra information to help interpret the hint. A correct recognition of the hint at this stage scores 1. Total score can be 0-20, with a higher score being a better outcome.
Baseline and posttest (approximately 6 weeks after baseline)
Greater sustained employment by 9 Months
Time Frame: 9 Month Follow Up (approximately 9 Months after randomization)
Self-report employment surveys completed at baseline and follow ups. Employment will be tracked as 0 (no job) and 1 (job). Higher scores indicate a better outcome.
9 Month Follow Up (approximately 9 Months after randomization)
Change in Managing Emotions
Time Frame: Baseline and posttest (approximately 6 weeks after baseline)
The Mayer-Salovey-Caruso Emotional Intelligence Test (MSCEIT) is an ability-based test designed to measure the four branches of the EI model of Mayer and Salovey. This study will only use the Managing Emotions Subscale, which measures the ability to be be open to emotions and feelings and integrate emotions with thinking. There are 29 scenarios presented, with higher score ranges indicating a positive outcome and lower score ranges indicating a worse outcome. The score ranges are as follows: Improve (worse), Consider Developing, Competent, Skilled, and Expert (positive).
Baseline and posttest (approximately 6 weeks after baseline)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Anxiety
Time Frame: Baseline and posttest (approximately 6 weeks after baseline)
Measured by the Social Interaction Anxiety Scale (SIAS) self-report survey. Items are on a 5 point scale with 0 being "not at all" and 4 being "extremely". Total score can be 0-80, with higher scores indicating higher anxiety, a worse outcome.
Baseline and posttest (approximately 6 weeks after baseline)

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Social Competence/Applied Social Ability
Time Frame: Baseline and posttest (approximately 6 weeks after baseline)
Measured by Social Skills Performance Assessment (SSPA). Roleplay performance: The SSPA includes two brief (3-minute) roleplays in which participants engage in a conversation with an unknown confederate who plays the role of a new neighbor(NN) or a landlord (LL). The NN and LL role plays were video recorded at the pre- and posttest visits and were blindly rated by use of an anchoring system. The NN roleplay was scored on eight items via a 5-point scale (e.g., 5,very interested, to 1, very disinterested), and the LL roleplay was scored on nine items via a 5-point scale (e.g., 5,very focused, to 1, very unfocused). The two role-play scores were combined to create one total pretest score and one total posttest score. Sum scores could have a minimum of 17 and maximum of 85. Higher scores indicated better skills.
Baseline and posttest (approximately 6 weeks after baseline)
Change in Interpersonal Communication at Work
Time Frame: Baseline and posttest (approximately 6 weeks after baseline) and 3-month, 6-month, 9-month follow up after randomization.
Measured by the Interpersonal Communication at Work Scale. There are 4 items on a scale from 1 (Less than once per month or never) to 5 (several times per day). A higher score indicates a more negative outcome.
Baseline and posttest (approximately 6 weeks after baseline) and 3-month, 6-month, 9-month follow up after randomization.
Change in Job Satisfaction
Time Frame: Baseline and posttest (approximately 6 weeks after baseline) and 3-month, 6-month, 9-month follow up after randomization.
Measured by the Job Satisfaction of Persons with Disability Scale. There are 14 items on a scale from 1 Strongly Disagree to 7 Strongly Agree with a higher score indicating a more positive score. Total scores can range from 14-98.
Baseline and posttest (approximately 6 weeks after baseline) and 3-month, 6-month, 9-month follow up after randomization.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Matthew J Smith, PhD, University of Michigan

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 7, 2023

Primary Completion (Actual)

July 25, 2025

Study Completion (Actual)

July 25, 2025

Study Registration Dates

First Submitted

July 7, 2023

First Submitted That Met QC Criteria

July 14, 2023

First Posted (Actual)

July 17, 2023

Study Record Updates

Last Update Posted (Actual)

December 8, 2025

Last Update Submitted That Met QC Criteria

December 1, 2025

Last Verified

December 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • HUM00228606
  • R44MH123359-01 (U.S. NIH Grant/Contract)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Autism Spectrum Disorder

Clinical Trials on Work Chat

Subscribe